NDC 51672-1309-01 - Betamethasone Dipropionate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-1309
- Requested NDC
- 51672-1309-01
- Package NDCs from labels
- 51672-1309-1, 51672-1309-3, 51672-1309-01
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc.
- Effective date
- 2025-07-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Betamethasone Dipropionate Gel (Augmented*), 0.05% | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | 2025-07-02 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-1309-1 | Betamethasone Dipropionate | 15 g in 1 TUBE | GEL | 15 | 6 | |
| 51672-1309-1 | Betamethasone Dipropionate | 1 in 1 CARTON | GEL | 1 | 6 | |
| 51672-1309-3 | Betamethasone Dipropionate | 1 in 1 CARTON | GEL | 1 | 6 | |
| 51672-1309-3 | Betamethasone Dipropionate | 50 g in 1 TUBE | GEL | 50 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-1309 | BETAMETHASONE DIPROPIONATE GEL [TARO PHARMACEUTICALS U.S.A., INC.] | 5 | Current NDC, Legacy NDC, 4 package rows | 20241222_e041ceb2-8bda-4703-b663-804e7b462e32.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-1309-1 | GM - Gram | 51672-1309 | 8f10039b-85a5-4ecd-bcea-3bab503cd157 | 1 | 2012-07-24 |
| 51672-1309-3 | GM - Gram | 51672-1309 | aaa573ed-58dc-4041-9cbf-2a97c4d5b376 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Betamethasone Dipropionate | ACTIVE INGREDIENT | 826Y60901U | BETAMETHASONE DIPROPIONATE GEL [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| Betamethasone | ACTIVE MOIETY | 9842X06Q6M | BETAMETHASONE DIPROPIONATE GEL [TARO PHARMACEUTICALS U.S.A., INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | beda35c3-9a8b-47ad-e053-2995a90a7b1b | 2025-11-24 | Warnings | 059QF0KO0R |
| Easy Care First Aid Eyewash | WATER | Tender Corporation | a070aac8-e6d2-ef10-e053-2a95a90aa5b1 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | e07a064b-f680-405c-bbcd-24fac430951e | 2025-11-24 | Warnings | 059QF0KO0R |
| ULINE Eyewash | EYEWASH | Niagara Pharmaceuticals Inc. | 2d7f22d2-320b-6af1-e063-6294a90addc6 | 2025-11-24 | Warnings | 059QF0KO0R |
| Pur-Wash | EYEWASH | Niagara Pharmaceuticals, Inc. | 0d43b1c1-2699-37f1-e054-00144ff88e88 | 2025-11-24 | Warnings | 059QF0KO0R |
| Eyewash Station Additive Concentrate | CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL | Niagara Pharmaceuticals Inc. | 362a6b6d-862d-4322-87a8-5b3a07fbe174 | 2025-11-24 | Warnings | 6DC9Q167V3 |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 777e1559-786f-8d54-e053-2991aa0aa98d | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 7289103a-5cbf-42f4-8848-e827149a43ca | 2025-11-24 | Warnings | 059QF0KO0R |
| Eyewash Additive Concentrate | WATER AND PROPYLENE GLYCOL | Haws Corporation | dd168403-398c-41ff-b1df-d93e4ff39de3 | 2025-11-20 | Warnings | 6DC9Q167V3 059QF0KO0R |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Prasco Laboratories | f5b50c00-cc6f-4296-a9ae-b16888cef4dd | 2025-11-19 | Warnings, Adverse reactions | 826Y60901U |
| DIPROLENE | BETAMETHASONE DIPROPIONATE | Organon LLC | 0b9543ad-2ca7-430d-aef9-81c376dc2e6c | 2025-11-19 | Warnings, Adverse reactions | 826Y60901U |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | fd823bef-c14c-4708-a18a-8aaa8470412f | 2025-11-18 | Warnings, Adverse reactions | 059QF0KO0R |
| Betamethasone dipropionate | BETAMETHASONE DIPROPIONATE | Lupin Pharmaceuticals, Inc. | 216d5b7f-4236-4882-b899-be17cb1a1584 | 2025-11-13 | Warnings, Adverse reactions | 826Y60901U |
| Eyesaline Eyewash Concentrate | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 3765c251-eb14-d60f-e063-6294a90a6a4d | 2025-11-12 | Warnings | 059QF0KO0R |
| Eyesaline Emergency Eyewash | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 37f244fd-c02f-e66a-e063-6394a90aed81 | 2025-11-12 | Warnings | 059QF0KO0R |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Encube Ethicals, Inc. | 7e946599-2fb4-4426-bb59-fbb71d89dac8 | 2025-11-11 | Warnings, Adverse reactions | 826Y60901U |
| STERILE WATER | WATER | Henry Schein, Inc. | f4087143-9868-4308-b96c-43657ee8ec28 | 2025-11-07 | Warnings, Adverse reactions | 059QF0KO0R |
| Bacteriostatic Water | BACTERIOSTATIC WATER | ProPharma Distribution | 42c6938e-f747-ae13-e063-6294a90a59a3 | 2025-11-04 | Warnings, Adverse reactions | 059QF0KO0R |
| Systane Complete PF | PROPYLENE GLYCOL EMULSION | Alcon Laboratories, Inc. | 798ffdde-1dba-4a3f-a0b6-937f9e958cca | 2025-11-03 | Warnings | 6DC9Q167V3 |
| Sterile Water | WATER | ICU Medical Inc. | aab10f03-26ae-4dbc-a481-ef025e48b405 | 2025-11-02 | Warnings, Adverse reactions | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.